Milameline

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Milameline
Milameline.png
Systematic (IUPAC) name
(E)-N-methoxy-1-(1-methyl-1,2,5,6-tetrahydropyridin-3-yl)methanimine
Clinical data
Legal status ?
Identifiers
CAS number 139886-32-1
ATC code None
PubChem CID 9571002
ChemSpider 7845468
UNII R9X77R42FN YesY
Chemical data
Formula C8H14N2O 
Mol. mass 154.21 g/mol

Milameline (CI-979, PD-129,409, RU-35,926) is a non-selective muscarinic acetylcholine receptor partial agonist with cognition-acting properties that was being investigated for the treatment of Alzheimer's disease, but produced poor results in clinical trials and was subsequently discontinued.[1]

See also[edit]

References[edit]

  1. ^ Sedman AJ, Bockbrader H, Schwarz RD (1995). "Preclinical and phase 1 clinical characterization of CI-979/RU35926, a novel muscarinic agonist for the treatment of Alzheimer's disease". Life Sciences 56 (11-12): 877–82. doi:10.1016/0024-3205(95)00023-Y. PMID 10188788.